India looks to US companies to invest in pharmaceutical and medical device sector

India has contacted major U.S. pharmaceutical companies seeking investment in the country’s pharmaceutical and medical device sector, which is gaining urgency amid a devastating second wave of the coronavirus pandemic. Indian Ambassador to the United States Taranjit Singh Sandhu held virtual meetings with Alberta Bourla, CEO of Pfizer, CEO of Thermo Fisher Marc Casper, Bernd Brust, President and CEO of Antylia Scientific, and Joseph Repp, CEO of Pall Life Sciences.

He also had a call with Emmanuel Ligner, CEO and President of Cytiva. During his interactions with pharmaceutical companies, Sandhu mentioned that India is seeking to encourage investment in the pharmaceutical and medical device sector.

India, he said, recently launched a production-linked incentive program that will provide US companies with new investment opportunities. “We discussed ways in which Pfizer could support health efforts, including vaccines in India, and strengthen our response to the pandemic,” Sandhu said after meeting with Bourla last week.

On Monday, Bourla said that Pfizer was following the plight of COVID-19 in India with deep concern and that his company was doing everything possible to provide support. “Today we announced that we are mobilizing the largest humanitarian relief effort in our company’s history to help the Indian people fight the vicious second wave of coronavirus currently ravaging the country,” he said. declared.

Among other things, he announced that he had donated enough of his $ 70 million worth of drugs to ensure that every COVID-19 patient in every public hospital across India could access them for free within 90 next days. “This effort has the potential to impact the lives of hundreds of thousands of patients,” Bourla said.

During his meeting with Thermo Fisher CEO Marc Casper, Sandhu highlighted their important role in the fight against the pandemic, including shipping supplies to India of raw materials for the Covishield vaccine as well as essential drugs such as remdesivir.

Massachusetts-based Thermo Fisher is a critical company in the biopharmaceutical supply chain. It offers analytical instruments, laboratory equipment, chemicals and supplies to pharmaceutical and biotechnology companies, hospitals and clinical diagnostic laboratories, universities, research institutes and government agencies. During his meeting with Repp, CEO of Pall Life Sciences, the Indian Ambassador discussed strengthening supply chains and accelerating inputs for essential drugs such as Remdesivir and the Novavax vaccine.

Pall Biotech products have played a key role in life-saving drugs ranging from Ebola virus vaccines to monoclonal cancer antibodies. Its products are extremely relevant given the current pandemic situation and are part of critical industry supply chains. The company has an extensive network in India, including offices in Mumbai, Ahmedabad, Hyderabad, Chandigarh, Delhi and Bangalore.

Sandhu during his call with Bernd Brust, Chairman and CEO of Antylia Scientific, appreciated his company’s efforts to ensure timely supplies for the Covishield and Novavax vaccines. Antylia Scientific is a global expert in peristaltic and single-use bioprocessing solutions, with a diverse portfolio of life science and diagnostic products for the pharmaceutical, biopharmaceutical, healthcare and environmental markets.

The Ambassador also had a call with Emmanuel Ligner, CEO and President of Cytiva, a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutic products.

Read all the latest news, breaking news and coronavirus news here


Source link

About Catherine Sherrill

Check Also

The Closed System Transfer Device market is expected to witness notable growth owing to the increase in the use of oncology drugs and the emergence of new protocols in the pharmaceutical industry, according to TMR

ALBANY, NY, 23 November 2021 / PRNewswire / – The growing adoption of closed system …

Leave a Reply

Your email address will not be published. Required fields are marked *